September 4 marks World Sexual Health Day 2026. This year’s theme, “Every Body,” reminds us of an important fact: Sexual health is not one-size-fits-all.

People have different health needs. Communities face different testing challenges. Healthcare providers require different levels of diagnostic information.

From prevention and screening to diagnosis and treatment monitoring, access to the right diagnostic information can help support better-informed healthcare decisions for everybody.

At Macro & Micro-Test, we are committed to supporting sexual and reproductive health with a flexible molecular diagnostic portfolio designed for different populations, clinical scenarios and laboratory workflows.

From Screening to Comprehensive Molecular Testing

Sexual and reproductive health encompasses a wide range of diagnostic needs.A population screening program calls for broad and efficient detection to maximize coverage. A patient presenting with symptoms requires a focused yet comprehensive panel to quickly identify the causative pathogen(s). Complex, recurrent, or refractory cases often demand high-plex comprehensive testing to uncover co-infections, resistance markers, or less common pathogens.

That’s why flexibility matters.

Macro & Micro-Test provides scalable molecular testing solutions across key areas of sexual and reproductive health—including HPV, sexually transmitted infections (STIs) and vaginal health assessment.

HPV Testing: Flexible Options for Different Clinical Needs

HPV testing remains an important part of cervical cancer prevention and reproductive health management. Different screening and clinical strategies require different levels of molecular information.

Macro & Micro-Test provides a comprehensive HPV testing portfolio covering:

-Flexible sampling—swab or non-invasive urine

-Broad HPV detection

-Targeted typing and full genotyping

-E6/E7 mRNA detection

-Liquid and lyophilized reagent formats

-Selected assays compatible with the sample-to-answer Eudemon™ AIO800

From broad screening to extended molecular characterization, laboratories can select testing approaches that best fit their clinical and workflow requirements.

STI Testing: Choose the Right Panel for the Right Setting

Sexually transmitted infections do not present uniformly—clinical demands vary across patient populations, disease prevalence, and testing objectives. A routine monitoring scenario may call for focused, cost-effective detection; a symptomatic patient may require broader coverage to pinpoint the causative pathogen; and complex or recurrent cases often demand the highest level of multiplexing to uncover co-infections, resistant strains, or atypical pathogens.

That is why one-size-fits-all does not work in STI testing.

Macro & Micro-Test addresses this challenge with a scalable multiplex PCR portfolio—all built on the same reliable platform, all using convenient swab or urine samples, and all delivering the same high standard of accuracy. Whether you need a simple single-target assay or an ultra-comprehensive 18-plex panel, our portfolio adapts seamlessly to your clinical or research setting.

One platform. Flexible panels. Consistent performance. Our scalable STI solutions ensure that you never over-test or under-test—you simply test right.

Beyond Individual Pathogens: A Broader View of Vaginal Health

Not every vaginal health challenge can be explained by a single pathogen. Shifts in microbiota, overgrowth of opportunistic organisms, and antimicrobial resistance genes can all contribute—often simultaneously.

The Macro & Micro-Test Women’s Health Advanced Nucleic Acid Detection Kit provides a more complete picture by detecting 20 clinically relevant targets in a single assay, covering:

-Vaginal microbiota & BV-associated organisms – Atopobium vaginae, Megasphaera types 1 & 2, Mobiluncus curtisii & mulieris, BVAB-2, Prevotella bivia, Gardnerella vaginalis, and Lactobacillus iners.

-Opportunistic pathogens – Candida albicans, E. coli, S. aureus, S. agalactiae, E. faecalis, E. faecium, and U. urealyticum.

-Antimicrobial resistance markers – TetM, mefA, ermB, and blaTEM.

By integrating microbiota assessment, pathogen detection, and AMR analysis into one workflow, the kit delivers actionable insights—not just more data.

Compatible with mainstream real-time PCR platforms and Eudemon™ AIO800. Uses cervical/vaginal swabs. Room-temperature storage (2–25°C), 12-month shelf life.

One sample. One assay. A complete molecular view.

One Health Need. Different Testing Pathways.

Better sexual health requires more than a single test. It requires diagnostic solutions that can adapt to different:

People.
Populations.
Clinical questions.
Healthcare settings.
Laboratory workflows.

From HPV screening and genotyping, to scalable STI detection, to comprehensive molecular assessment of vaginal health, Macro & Micro-Test is building flexible molecular testing solutions to support more informed healthcare decisions- for every body, in every setting.

Because no two clinical situations are exactly the same. And no single testing approach fits every need.

This World Sexual Health Day, we stand for better awareness, better access and better diagnostics—for Every Body.

Every Body. Every Need. Every Step Toward Better Sexual Health.